Alterity Therapeutics (ATHE) Stock Chart & Stock Price History $5.02 -0.08 (-1.57%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$5.02 0.00 (0.00%) As of 04:55 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alterity Therapeutics Stock Price Performance The Alterity Therapeutics (ATHE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 286.15%, with a year-to-date return of 51.66%. In the past month, the stock has decreased 23.36%, reflecting recent market activity. As of the latest close, Alterity Therapeutics traded at $5.02 with a market cap of $44.53 million and volume of 13,715 shares. Receive ATHE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.20%1 Month Performance-23.36%3 Month Performance+18.12%Year-To-Date Performance+51.66%1 Year Performance+286.15% ATHE Stock Chart for Monday, August, 25, 2025 ATHE Chart by TradingView Alterity Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$5.10$5.02-1.57%$5.13$4.9513,715 shs$44.53 million08/21/2025$5.03$5.10+1.39%$5.11$4.908,030 shs$45.24 million08/20/2025$4.95$5.03+1.62%$5.14$4.9019,115 shs$44.60 million08/19/2025$5.22$4.95-5.17%$5.27$4.9515,795 shs$43.91 million08/18/2025$5.21$5.22+0.19%$5.39$5.166,153 shs$46.30 million08/15/2025$5.23$5.21-0.38%$5.25$5.154,846 shs$46.21 million08/14/2025$5.14$5.23+1.75%$5.24$5.0810,236 shs$46.37 million08/13/2025$5.30$5.14-3.02%$5.33$5.1318,738 shs$45.59 million08/12/2025$5.32$5.30-0.38%$5.51$5.1539,837 shs$47.01 million08/11/2025$5.40$5.32-1.48%$5.55$5.2617,554 shs$47.17 million Get the Latest News and Ratings for ATHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$5.31$5.40+1.69%$5.56$5.1736,738 shs$47.90 million08/07/2025$5.15$5.31+3.11%$5.43$5.1017,721 shs$47.08 million08/06/2025$5.40$5.15-4.63%$5.42$5.1026,909 shs$45.68 million08/05/2025$5.21$5.40+3.65%$5.44$5.2138,776 shs$47.90 million08/04/2025$5.01$5.21+3.99%$5.34$5.0924,776 shs$46.20 million08/01/2025$5.06$5.01-0.99%$5.15$4.8745,942 shs$44.42 million07/31/2025$5.17$5.06-2.13%$5.35$5.0076,024 shs$44.88 million07/30/2025$5.34$5.17-3.18%$5.36$5.1257,287 shs$45.86 million07/29/2025$5.58$5.34-4.30%$5.52$5.13158,876 shs$47.35 million07/28/2025$6.55$5.58-14.81%$6.03$4.981.89 million shs$49.50 million07/25/2025$5.68$6.55+15.32%$7.00$5.85257,581 shs$58.10 million07/24/2025$4.99$5.68+13.83%$5.83$5.31124,458 shs$50.38 million Related Companies SXTC Stock Chart KRRO Stock Chart CRBU Stock Chart CCCC Stock Chart TVGN Stock Chart SLS Stock Chart ENTA Stock Chart LFVN Stock Chart CYBN Stock Chart ACTU Stock Chart Receive ATHE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ATHE) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alterity Therapeutics Limited - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Alterity Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access